expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms | The Royal Society of Canada
COVID-19: More than half of Canada's AstraZeneca vaccine doses will be thrown out | CTV News
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
RACGP - Victoria reduces interval for vaccine doses
Covid: Germany approves AstraZeneca vaccine for over-65s - BBC News
Ten month gap between AstraZeneca doses sees highest antibody boost: Oxford study - The Hindu
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
Oxford/AstraZeneca study supports UK decision to delay second doses | Financial Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HAL7CJGM4VNMRJB2XV3KMU2EYY.jpg "Thailand to extend dose gap for AstraZeneca vaccine to 16 weeks | Reuters")
Thailand to extend dose gap for AstraZeneca vaccine to 16 weeks | Reuters
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
How long should you wait to get the second AstraZeneca jab? - ABC News
Study finds AstraZeneca COVID-19 vaccine may reduce virus transmission - Los Angeles Times
Changing the UK COVID-19 vaccine dosing schedule - POST
Delaying AstraZeneca second dose for 10 months 'boosts response' - CGTN
Comparing vaccines: efficacy, safety and side effects - Healthy Debate
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FUVLYOUSVNLFXAAYQUQTDNCZNY.jpg "Ireland allows AstraZeneca vaccine for all adults, cuts dose gap | Reuters")
Ireland allows AstraZeneca vaccine for all adults, cuts dose gap | Reuters
AstraZeneca vaccine: 3-month dosage interval might be preferable
Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds - The New York Times
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model | Scientific Reports
Oxford/AstraZeneca study supports UK decision to delay second doses | Financial Times
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
